1. Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. Natl Health Stat Report 2012;(60):1-25.
2. Podolsky ML, Desai NA, Waters TP, Nyirjesy P. Hysteroscopic tubal occlusion: sterilization after failed laparoscopic or abdominal approaches. Obstet Gynecol 2008;111(2 Pt 2):513-515. PMID:
18239004.
3. Yang R, Ma C, Qiao J, Li TC, Yang Y, Chen X, et al. The usefulness of transvaginal hydrolaparoscopy in infertile women with abnormal hysterosalpingogram results but with no obvious pelvic pathology. Eur J Obstet Gynecol Reprod Biol 2011;155:41-43. PMID:
21111527.
4. Kraemer DF, Yen PY, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception 2009;80:254-260. PMID:
19698817.
5. Chapa HO, Venegas G. Preprocedure patient preferences and attitudes toward permanent contraceptive options. Patient Prefer Adherence 2012;6:331-336. PMID:
22563241.
6. Yu E. Technical specifications provided by Conceptus Office of Regulatory Affairs: product information. Materials in the Essure system (ESS305). Whippany (NJ): Bayer HealthCare Pharmaceuticals; 2007.
7. Lessard CR, Hopkins MR. Efficacy, safety, and patient acceptability of the Essure procedure. Patient Prefer Adherence 2011;5:207-212. PMID:
21573052.
8. Ricci G, Restaino S, Di Lorenzo G, Fanfani F, Scrimin F, Mangino FP. Risk of Essure microinsert abdominal migration: case report and review of literature. Ther Clin Risk Manag 2014;10:963-968. PMID:
25484591.
9. Jost S, Huchon C, Legendre G, Letohic A, Fernandez H, Panel P. Essure permanent birth control effectiveness: a seven-year survey. Eur J Obstet Gynecol Reprod Biol 2013;168:134-137. PMID:
23375900.
10. Arora P, Arora RS, Cahill D. Essure for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis. BJOG 2014;121:527-536. PMID:
24393165.
11. Deardorff J. New study: Essure less effective than tubal ligation at preventing pregnancy. Chicago Tribune 2014;4 21 Sect. A. 2.
12. Gariepy AM, Creinin MD, Smith KJ, Xu X. Probability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization. Contraception 2014;90:174-181. PMID:
24767963.
14. Kotz S, Nadarajah S. Extreme value distributions: theory and applications. London: Imperial College Press; 2000.
15. Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404. PMID:
21477680.
16. Leyser-Whalen O, Berenson AB. Adherence to hysterosalpingogram appointments following hysteroscopic sterilization among low-income women. Contraception 2013;88:697-699. PMID:
24012097.
17. Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a microinsert device: results of a multicentre Phase II study. Hum Reprod 2003;18:1223-1230. PMID:
12773450.
18. Savage UK, Masters SJ, Smid MC, Hung YY, Jacobson GF. Hysteroscopic sterilization in a large group practice: experience and effectiveness. Obstet Gynecol 2009;114:1227-1231. PMID:
19935023.
19. Shavell VI, Abdallah ME, Diamond MP, Kmak DC, Berman JM. Post-Essure hysterosalpingography compliance in a clinic population. J Minim Invasive Gynecol 2008;15:431-434. PMID:
18588851.
20. Guiahi M, Goldman KN, McElhinney MM, Olson CG. Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization. Contraception 2010;81:520-524. PMID:
20472120.
21. Anderson TL, Yunker AC, Scheib SA, Callahan TL. Hysteroscopic sterilization success in outpatient vs office setting is not affected by patient or procedural characteristics. J Minim Invasive Gynecol 2013;20:858-863. PMID:
23891205.